2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
44
Esophageal Squamous Cell Carcinoma
18
Carcinoma, Squamous Cell
6
Neoplasms
4
Adenocarcinoma
4
Sarcopenia
2
Radiation Injuries
2
Obesity
2
Anastomotic Leak
2
Stomach Neoplasms
1
Respiratory Insufficiency
1
Radiation Pneumonitis
1
Radiation Fibrosis Syndrome
1
Pulmonary Fibrosis
1
Postoperative Complications
1
Pneumonia
1
Pathologic Complete Response
1
Pain, Postoperative
1
Osteoporosis
1
Obesity, Abdominal
1
Neoplastic Cells, Circulating
1
National Cancer Center/Cancer Hospital
1
Motor Activity
1
Margins of Excision
1
Lymphatic Metastasis
1
Loco-regional Esophageal Cancer
1
Esophageal Diseases
1
Deglutition Disorders
1
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
1
Brain Neoplasms
1
Interventions
camrelizumab
2
Radiation
2
sintilimab
1
Tumor Burden
1
Pyloromyotomy
1
Paclitaxel
1
Ocoxin
1
Itraconazole
1
Fluorouracil
1
Esophagectomy
1
Erlotinib Hydrochloride
1
Cisplatin
1
Botulinum Toxins, Type A
1
Blood Specimen Collection
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Diseases
×
Esophagectomy
×
Clear all
NCT01927016
2026-05-14
FREGAT I
University Hospital, Lille
Completed
2,944 enrolled